Soru

Zorluk: ZorOrdering Laboratory Tests

A 32-year-old woman is evaluated in the preoperative clinic prior to an elective laparoscopic cholecystectomy. She has no significant past medical history and takes no medications. She reports normal menstrual periods and denies any history of easy bruising, epistaxis, or prolonged bleeding after minor cuts or prior dental extractions. Routine preoperative laboratory testing reveals a normal prothrombin time (PT) of 11.5 seconds and an isolated, significantly prolonged activated partial thromboplastin time (aPTT) of 62 seconds (reference range: 25-35 seconds). Her platelet count is 210,000/μL210,000/\mu L.

Arrange the following laboratory tests in the most appropriate sequential order to establish the etiology of this patient's isolated prolonged aPTT, from the initial evaluation step to the final diagnostic confirmation.

  1. 11:1 mixing study with normal pooled plasma
  2. 2Dilute Russell viper venom time (dRVVT) screening test
  3. 3Confirmatory testing with excess exogenous phospholipids
  4. 4Solid-phase enzyme-linked immunosorbent assay (ELISA) for anticardiolipin and anti-beta-2 glycoprotein I antibodies

Cevap

The correct sequence is: 1:1 mixing study with normal pooled plasma -> Dilute Russell viper venom time (dRVVT) screening test -> Confirmatory testing with excess exogenous phospholipids -> Solid-phase ELISA for anticardiolipin and anti-beta-2 glycoprotein I antibodies.
The correct diagnostic sequencing for an asymptomatic patient with an isolated prolonged aPTT begins with a 1:1 mixing study. Because the patient has no bleeding history, the mixing study will typically fail to correct, indicating an inhibitor rather than a factor deficiency. The most common inhibitor in an asymptomatic patient is a lupus anticoagulant. The presence of a lupus anticoagulant is functionally evaluated using the dRVVT screening test, which will be prolonged. This must be immediately followed by a confirmatory step adding excess phospholipids, which overwhelms the inhibitor and corrects the clotting time, proving phospholipid dependence. Finally, specific serologic testing (ELISA for anticardiolipin and anti-beta-2 glycoprotein I antibodies) is ordered to complete the diagnostic triad for antiphospholipid syndrome.

Adım Adım Çözüm

1
Perform a 1:1 mixing study with normal pooled plasma.
Determines if the isolated prolonged aPTT is due to an inhibitor (fails to correct) or a factor deficiency (corrects).
This is the fundamental first branching point in evaluating any unexplained prolongation of a coagulation assay.
2
Order a dilute Russell viper venom time (dRVVT) screening test.
Evaluates the patient's plasma for the presence of a lupus anticoagulant.
Given the patient's lack of bleeding history and suspected inhibitor, a lupus anticoagulant is highly probable. dRVVT directly activates Factor X, making it sensitive to phospholipid-dependent inhibitors.
3
Perform confirmatory testing with excess exogenous phospholipids.
Corrects the previously prolonged dRVVT.
Definitively proves that the inhibitor identified in the screening step is phospholipid-dependent, which is the functional hallmark of a lupus anticoagulant.
4
Order solid-phase ELISAs for specific antiphospholipid antibodies.
Identifies the presence of anticardiolipin and/or anti-beta-2 glycoprotein I antibodies.
Completes the comprehensive serologic evaluation for antiphospholipid syndrome per the Sapporo/Sydney diagnostic criteria.

Anahtar Kavram

Algorithmic laboratory evaluation of an isolated prolonged aPTT and suspected lupus anticoagulant
Bu soruyu puanla